MOBILE, Ala., Aug. 3, 2011 /PRNewswire/ -- HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced the combined audited 2010 year-end results and the unaudited combined 2011 first quarter results for HASCO Medical, Mobility Freedom (www.MobilityFreedom.com) and Wheelchair Vans of America (www.WCvans.com).
Combined financial highlights for HASCO Medical and Mobility Freedom:
- Total combined revenue for HASCO and its subsidiaries during the 2010 year-end was $12,429,531.
- Mobility Freedom Van Sales for 2010 increased to $9,835,075 from $6,335,664 for 2009 year-end.
- Mobility Freedom Van Rentals for 2010 increased to $436,926 from $301,824 for the 2009 year-end.
- Mobility Freedom Net Income for 2010 increased to $566,753 from $274,701 for the 2009 year-end.
- For the three months ended March 31, 2011, Mobility Freedom Van Sales increased $33,518 to $2,133,736 compared to the same period 2010.
- For the three months ended March 31, 2011, Mobility Freedom Net income increased $55,767 to $162,482 compared to the same period 2010.
To view the 8K filing and the combined financial charts in their entirety, please click on the following link:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8050761
About HASCO Medical, Inc.
HASCO Medical (“HASC” or the Company) provides products and services that dramatically improve the quality of living for its customers. The Company’s products and services include the sale of durable medical equipment, home respiratory equipment and the sale or rental of wheelchair accessible vans for which it provides custom conversion services. The Company operates in the South Eastern portion of the United States including Alabama, Mississippi and Florida. The Company’s objective is to be a leading provider of home health care products and services in the continental United States.
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called “forward looking statements” by words such as “may,” “will,” “should,” “expects,” “plans,” “targets,” “believes,” “anticipates,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company’s filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
SOURCE HASCO Medical, Inc.
